Volume 102, Issue 11

Search all Annals of Hematology articles

November 2023

Filter by

Volume:

Sort by

Date published:

New to old Old to new

38 articles in this issue

Risk factors for thromboembolic events in patients with paroxysmal nocturnal hemoglobinuria (PNH): a nested case–control study in the International PNH Registry
Britta Höchsmann
Regis Peffault de Latour
Jong Wook Lee
Original Article Open access 05 September 2023 Pages: 2979 - 2988
Delay in treatment of adult hemophagocytic lymphohistiocytosis is associated with worse in-hospital outcomes
Ali Abdelhay
Amir Mahmoud
Omar Ammari
Original Article 01 July 2023 Pages: 2989 - 2996
Alternative treatment modality for severe aplastic anemia in a resource-limited setting: a single-institution prospective cohort study from Upper Egypt
Mervat A M Youssef
Mohammed H Ghazaly
Mai A Abdelfattah
Original Article Open access 13 September 2023 Pages: 2997 - 3006
Bleeding risk assessment in immune thrombocytopenia
Kundan Mishra
Aditya Jandial
Pankaj Malhotra
Original Article 23 September 2023 Pages: 3007 - 3014
Reliability of flow-cytometry in diagnosis and prognostic stratification of myelodysplastic syndromes: correlations with morphology and mutational profile
Luca Guarnera
Emiliano Fabiani
Luca Maurillo
Original Article Open access 03 August 2023 Pages: 3015 - 3023
Gilteritinib and the risk of intracranial hemorrhage: a case series of a possible, under-reported side effect
Salvatore Perrone
Stefano Imperatore
Matteo Molica
Original Article Open access 22 August 2023 Pages: 3025 - 3030
Predictors of very early death in acute promyelocytic leukemia: a retrospective real-world cohort study
Joana Infante
Graça Esteves
João Forjaz de Lacerda
Original Article Open access 31 August 2023 Pages: 3031 - 3037
Treatment of refractory or relapsed myelodysplastic neoplasms with luspatercept: a multicenter Chinese study
Zhuxin Zhang
Qinglin Hu
Bing Han
Original Article 08 September 2023 Pages: 3039 - 3047
Spliceosome mutations are associated with clinical response in a phase 1b/2 study of the PLK1 inhibitor onvansertib in combination with decitabine in relapsed or refractory acute myeloid leukemia
Peter J P Croucher
Maya Ridinger
Amer M. Zeidan
Original Article Open access 13 September 2023 Pages: 3049 - 3059
Real-world outcomes and prognostic factors among patients with acute myeloid leukemia treated with allogeneic hematopoietic stem cell transplantation
Qingya Wang
Zeyin Liang
Yuan Li
Original Article 04 September 2023 Pages: 3061 - 3074
Management and outcome of 500 multiple myeloma patients treated for first relapse outside clinical studies
Irit Avivi
Naama Yekutiel
Gabriel Chodick
Original Article 30 August 2023 Pages: 3075 - 3081
Treatment with idelalisib in patients with chronic lymphocytic leukemia – real world data from the registry of the German CLL Study Group
Julia von Tresckow
Nikola Heyl
Anna Maria Fink
Original Article Open access 26 June 2023 Pages: 3083 - 3090
Physical activity-related health competence and symptom burden for exercise prescription in patients with multiple myeloma: a latent profile analysis
Rea Kuehl
Maximilian Koeppel
Joachim Wiskemann
Original Article Open access 24 June 2023 Pages: 3091 - 3102
Dominant-negative type of IKZF1 deletion showed a favorable prognosis in adult B-cell acute lymphoblastic leukemia
Hiroyuki Kimura
Masahiro Onozawa
Takanori Teshima
Original Article 19 August 2023 Pages: 3103 - 3113
Prediction nomogram based on 18F-FDG PET/CT and clinical parameters for patients with diffuse large B-cell lymphoma
Xiaojuan Peng
Sisi Yu
Zhuzhong Cheng
Original Article 03 July 2023 Pages: 3115 - 3124
Generic ibrutinib a potential cost-effective strategy for the first-line treatment of chronic lymphocytic leukaemia
Naveen C Hegde
Ankit Kumar
Amol N Patil
Original Article 13 July 2023 Pages: 3125 - 3132
Evaluating the efficacy and toxicity of dose adjusted pegylated L-asparaginase in combination with therapeutic drug monitoring
Taylor D. Coe-Eisenberg
Anthony J. Perissinotti
Lydia Benitez
Original Article 22 July 2023 Pages: 3133 - 3141
“Sandwich” protocol based on modified SMILE regimen for children with newly extranodal NK/T cell lymphoma, nasal type: a single-arm, single-center clinical study
Cheng-qi Shen
Guo-qian He
Xia Guo
Original Article Open access 24 July 2023 Pages: 3143 - 3152
CCDC50, an essential driver involved in tumorigenesis, is a potential severity marker of diffuse large B cell lymphoma
Yuqi Gong
Hongyan Tong
Ren Zhou
Original Article Open access 09 September 2023 Pages: 3153 - 3165
Impact of primary prophylaxis by pegfilgrastim in diffuse large B-cell lymphoma treated with R-CHOP
Moonho Kim
Yongchel Ahn
Sang-Wook Yi
Original Article 21 August 2023 Pages: 3167 - 3175
Cytopenia: a report of haplo-cord transplantation in twin brothers caused by a novel germline GATA1 mutation and family survey
Xing-Hua Sun
Qin Liu
Hui Jiang
Original Article 18 July 2023 Pages: 3177 - 3184
Autologous hematopoietic stem cell transplantation improves survival outcomes in peripheral T-cell lymphomas: a multicenter retrospective real-world study
Meng Wu
Fengrong Wang
Jun Zhu
Original Article Open access 12 September 2023 Pages: 3185 - 3193
Impact of residual tumor cells in the stem cell collection on multiple myeloma patients receiving autologous stem cell transplantation
Jingyu Xu
Wenqiang Yan
Gang An
Original Article Open access 08 September 2023 Pages: 3195 - 3204
Salvage hematopoietic stem cell transplantation for patients with higher leukemia burden in relapsed or refractory acute myeloid leukemia: a ten-year study
Shan Jiang
Xuan Lu
Linghui Xia
Original Article 08 September 2023 Pages: 3205 - 3216
Excellent outcome of stem cell transplantation for sickle cell disease
Tanja Vallée
Irene Schmid
Michael H. Albert
Original Article Open access 19 September 2023 Pages: 3217 - 3227
A pilot study of cord blood-derived natural killer cells as maintenance therapy after autologous hematopoietic stem cell transplantation
Yuling Wu
Yue Wang
Ting Liu
Original Article 29 September 2023 Pages: 3229 - 3237
Association between ABO blood group/genotype and COVID-19 in a Japanese population
Tatsuya Kusumoto
Shotaro Chubachi
Koichi Fukunaga
Original Article 15 August 2023 Pages: 3239 - 3249
A novel prognosis-prediction model based on coagulation indicators in secondary hemophagocytic lymphohistiocytosis
Shixuan Wang
Kebing Lv
Fei Li
Original Article Open access 10 August 2023 Pages: 3251 - 3259
Bleeding pattern and consumption of factor VIII concentrate in adult patients with haemophilia A without inhibitors in the Czech Republic between 2013 and 2021 (Czech National Haemophilia Programme registry data)
Gabriela Romanová
Petr Smejkal
Miroslav Penka
Original Article Open access 23 September 2023 Pages: 3261 - 3270
Alemtuzumab induced acquired hemophilia A in multiple sclerosis: a case report
Hassan Fawaz
Mohammad Hassan Hodroj
Ali Taher
Letter to the Editor 22 July 2023 Pages: 3271 - 3273
Chronic neutrophilic leukemia with JAK2 mutation: is it true chronic neutrophilic leukemia?
Jiapei Gao
Junyin Gao
Fengling Min
Letter to the Editor Open access 31 July 2023 Pages: 3275 - 3276
Successful treatment of relapsed/refractory transformed aggressive B-cell lymphoma with polatuzumab vedotin combined with bendamustine and rituximab followed by non-myeloablative related HLA-haploidentical stem cell transplantation
Shigeki Kosugi
Masatoshi Kanno
Yasuyuki Inoue
Letter to the Editor 10 August 2023 Pages: 3277 - 3278
Hemophagocytosis by multinucleated leukemic blasts, basophilia, and micromegakaryocytes in AML with TLS::ERG
Xingqin Huang
Ting Li
Fang Long
Letter to the Editor 02 August 2023 Pages: 3279 - 3281
Successful use of thrombopoietin analogs in thrombocytopenia associated with MYH-9 mutation
María Louzao
María Teresa Vargas
María Eva Mingot-Castellano
Letter to the Editor 23 August 2023 Pages: 3283 - 3284
Quadruple stem cells transplantation of haploidentical bone marrow and PBSCs supporting by third-party umbilical cord blood and MSCs achieved excellent outcomes
Chengxin Luo
Xiaohong Li
Shuangnian Xu
Letter to the Editor 17 August 2023 Pages: 3285 - 3287
Recurrent arterial thrombosis as the primary symptom in a patient with polycythemia vera
Jia-hao Wen
Hua-liang Ren
Chun-min Li
Letter to the Editor 23 August 2023 Pages: 3289 - 3290
Daratumumab—a novel treatment strategy in relapsed/refractory acute leukemia
Pronamee Borah
Nitin Dayal
Rahul Naithani
Letter to the Editor 09 August 2023 Pages: 3291 - 3293
Successful treatment by CAR T-cells in multi-refractory mantle cell lymphoma with central nervous system involvement
Adrien Caillet
Caroline Houillier
Damien Roos-Weil
Letter to the Editor 15 August 2023 Pages: 3295 - 3297

Volume 102, Issue 11

Risk factors for thromboembolic events in patients with paroxysmal nocturnal hemoglobinuria (PNH): a nested case–control study in the International PNH Registry

Delay in treatment of adult hemophagocytic lymphohistiocytosis is associated with worse in-hospital outcomes

Alternative treatment modality for severe aplastic anemia in a resource-limited setting: a single-institution prospective cohort study from Upper Egypt

Bleeding risk assessment in immune thrombocytopenia

Reliability of flow-cytometry in diagnosis and prognostic stratification of myelodysplastic syndromes: correlations with morphology and mutational profile

Gilteritinib and the risk of intracranial hemorrhage: a case series of a possible, under-reported side effect

Predictors of very early death in acute promyelocytic leukemia: a retrospective real-world cohort study

Treatment of refractory or relapsed myelodysplastic neoplasms with luspatercept: a multicenter Chinese study

Spliceosome mutations are associated with clinical response in a phase 1b/2 study of the PLK1 inhibitor onvansertib in combination with decitabine in relapsed or refractory acute myeloid leukemia

Real-world outcomes and prognostic factors among patients with acute myeloid leukemia treated with allogeneic hematopoietic stem cell transplantation

Management and outcome of 500 multiple myeloma patients treated for first relapse outside clinical studies

Treatment with idelalisib in patients with chronic lymphocytic leukemia – real world data from the registry of the German CLL Study Group

Physical activity-related health competence and symptom burden for exercise prescription in patients with multiple myeloma: a latent profile analysis

Dominant-negative type of IKZF1 deletion showed a favorable prognosis in adult B-cell acute lymphoblastic leukemia

Prediction nomogram based on 18F-FDG PET/CT and clinical parameters for patients with diffuse large B-cell lymphoma

Generic ibrutinib a potential cost-effective strategy for the first-line treatment of chronic lymphocytic leukaemia

Evaluating the efficacy and toxicity of dose adjusted pegylated L-asparaginase in combination with therapeutic drug monitoring

“Sandwich” protocol based on modified SMILE regimen for children with newly extranodal NK/T cell lymphoma, nasal type: a single-arm, single-center clinical study

CCDC50, an essential driver involved in tumorigenesis, is a potential severity marker of diffuse large B cell lymphoma

Impact of primary prophylaxis by pegfilgrastim in diffuse large B-cell lymphoma treated with R-CHOP

Cytopenia: a report of haplo-cord transplantation in twin brothers caused by a novel germline GATA1 mutation and family survey

Autologous hematopoietic stem cell transplantation improves survival outcomes in peripheral T-cell lymphomas: a multicenter retrospective real-world study

Impact of residual tumor cells in the stem cell collection on multiple myeloma patients receiving autologous stem cell transplantation

Salvage hematopoietic stem cell transplantation for patients with higher leukemia burden in relapsed or refractory acute myeloid leukemia: a ten-year study

Excellent outcome of stem cell transplantation for sickle cell disease

A pilot study of cord blood-derived natural killer cells as maintenance therapy after autologous hematopoietic stem cell transplantation

Association between ABO blood group/genotype and COVID-19 in a Japanese population

A novel prognosis-prediction model based on coagulation indicators in secondary hemophagocytic lymphohistiocytosis

Bleeding pattern and consumption of factor VIII concentrate in adult patients with haemophilia A without inhibitors in the Czech Republic between 2013 and 2021 (Czech National Haemophilia Programme registry data)

Alemtuzumab induced acquired hemophilia A in multiple sclerosis: a case report

Chronic neutrophilic leukemia with JAK2 mutation: is it true chronic neutrophilic leukemia?

Successful treatment of relapsed/refractory transformed aggressive B-cell lymphoma with polatuzumab vedotin combined with bendamustine and rituximab followed by non-myeloablative related HLA-haploidentical stem cell transplantation

Hemophagocytosis by multinucleated leukemic blasts, basophilia, and micromegakaryocytes in AML with TLS::ERG

Successful use of thrombopoietin analogs in thrombocytopenia associated with MYH-9 mutation

Quadruple stem cells transplantation of haploidentical bone marrow and PBSCs supporting by third-party umbilical cord blood and MSCs achieved excellent outcomes

Recurrent arterial thrombosis as the primary symptom in a patient with polycythemia vera

Daratumumab—a novel treatment strategy in relapsed/refractory acute leukemia

Successful treatment by CAR T-cells in multi-refractory mantle cell lymphoma with central nervous system involvement

Navigation